Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

216.12

-12.60 (-5.51%)

At close: Aug 6, 2026, 4:00 PM EDT

216.12

0.00 (0.00%)

After-hours: Aug 6, 2026, 6:16 PM EDT

Alnylam Pharmaceuticals Revenue by Segment

Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Amvuttra	3.41B	2.89B	2.31B	1.77B	1.35B	1.09B	970.41M	859.20M
Amvuttra Growth	153.41%	166.66%	138.44%	106.44%	79.78%	66.62%	73.94%	90.43%
Collaboration	521.93M	536.26M	553.37M	619.37M	325.03M	490.83M	510.15M	479.60M
Collaboration Growth	60.58%	9.25%	8.47%	29.14%	-61.75%	-21.87%	-6.60%	-11.25%
Givlaari	324.83M	315.91M	308.49M	286.34M	283.46M	264.71M	255.85M	250.50M
Givlaari Growth	14.59%	19.34%	20.58%	14.31%	21.35%	15.39%	16.72%	21.01%
Royalty	228.22M	196.53M	174.02M	148.04M	125.23M	107.65M	91.79M	73.40M
Royalty Growth	82.24%	82.56%	89.59%	101.68%	109.07%	140.83%	126.08%	179.09%
Oxlumo	205.92M	200.67M	191.44M	185.36M	172.73M	166.46M	166.97M	156.10M
Oxlumo Growth	19.21%	20.55%	14.65%	18.75%	19.46%	29.85%	52.07%	54.71%
Onpattro	109.70M	143.78M	172.79M	197.21M	208.43M	233.09M	252.80M	275.70M
Onpattro Growth	-47.37%	-38.32%	-31.65%	-28.47%	-32.11%	-27.45%	-28.71%	-30.69%